Article
Cardiac stem cells
30 May 2002
Abstract excerpt
Augmentation of myocardial performance in experimental models of therapeutic infarction and heart failure has been achieved by the transplantation of exogenous cells into damaged myocardium, a procedure known as cellular cardiomyoplasty (CCM). Historically, a wide range of cell types have been used for CCM, including rat and human fetal ventricular myocytes, but the availability of human fetal donor cells for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
